The downregulation of METTL3 inhibits the ICAM2/PI3K/AKT/p300 signaling pathway, effectively slowing RA progression and further supporting the critical role of METTL3 in RA pathogenesis 121. This evidence concerns the gene AKT1 and rheumatoid arthritis.